Profound_Logo_CMYK copy.jpg
Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow
February 09, 2021 16:30 ET | Profound Medical Corp.
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Revenues
January 05, 2021 16:30 ET | Profound Medical Corp.
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound_Logo_CMYK copy.jpg
Profound Medical Signs Agreement with GE Healthcare to Expand Provider Access to TULSA-PRO®
December 21, 2020 07:30 ET | Profound Medical Corp.
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound_Logo_CMYK copy.jpg
Profound Medical Receives FDA HDE Approval for Sonalleve®
November 30, 2020 08:00 ET | Profound Medical Corp.
TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) announced today that Sonalleve® has received U.S. Food and Drug Administration...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Changes to its Board of Directors
November 30, 2020 07:45 ET | Profound Medical Corp.
TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound_Logo_CMYK copy.jpg
Profound Medical to Participate in November Virtual Investor Healthcare Conferences
November 10, 2020 16:30 ET | Profound Medical Corp.
TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Third Quarter 2020 Financial Results
November 05, 2020 16:02 ET | Profound Medical Corp.
TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound_Logo_CMYK copy.jpg
Profound Medical to Release Third Quarter 2020 Financial Results on November 5 – Conference Call to Follow
October 15, 2020 16:30 ET | Profound Medical Corp.
TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound_Logo_CMYK copy.jpg
Profound Medical to Present at the Cantor Virtual Global Healthcare Conference
September 09, 2020 16:30 ET | Profound Medical Corp.
TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound_Logo_CMYK copy.jpg
Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conference
August 10, 2020 08:00 ET | Profound Medical Corp.
TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...